Molecular Partners AG Share Price Nasdaq
Equities
MOLN
US60853G1067
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.781 USD | +2.19% | -2.55% | -9.54% |
Sales 2024 * | 13.86M 15.07M 1.26B | Sales 2025 * | 18.66M 20.29M 1.69B | Capitalization | 108M 118M 9.81B |
---|---|---|---|---|---|
Net income 2024 * | -59M -64.16M -5.35B | Net income 2025 * | -61M -66.33M -5.53B | EV / Sales 2024 * | 7.8 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 5.79 x |
P/E ratio 2024 * |
-1.94
x | P/E ratio 2025 * |
-1.77
x | Employees | 168 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.11% |
Latest transcript on Molecular Partners AG
1 day | +2.19% | ||
1 week | -2.55% | ||
1 month | -9.98% | ||
3 months | -20.90% | ||
6 months | +7.11% | ||
Current year | -9.54% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 52 | 23/04/23 | |
Patrick Amstutz
FOU | Founder | 49 | 23/04/23 |
Michael Pitzner
CMP | Compliance Officer | - | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
William Burns
CHM | Chairman | 76 | 31/17/31 |
Steven Holtzman
BRD | Director/Board Member | 70 | 19/14/19 |
Vito Palombella
BRD | Director/Board Member | 61 | 01/20/01 |
Date | Price | Change | Volume |
---|---|---|---|
30/24/30 | 3.781 | +2.19% | 4,726 |
29/24/29 | 3.7 | -4.64% | 2,558 |
26/24/26 | 3.88 | -.--% | 254 |
Delayed Quote Nasdaq, April 01, 2024 at 02:00 am IST
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-9.16% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |
- Stock Market
- Equities
- MOLN Stock
- MOLN Stock